WASHINGTON — A closely watched Alzheimer s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment s expected approval for people with
A closely watched Alzheimer s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment s expected approval for people with mild dementia caused by the brain-robbing disease.
Alzheimer s drug that can slow disease gets backing from FDA advisers wdio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wdio.com Daily Mail and Mail on Sunday newspapers.